Cuba Registers New Antibody

by Medindia Content Team on  June 26, 2006 at 4:08 PM General Health News
RSS Email Print This Page Comment bookmark
Font : A-A+

Cuba Registers New Antibody
Cuba's Center for Genetic Engineering and Biotechnology (CIGB) has registered the first recombinant monoclonal antibody to be used in the production of an anti-hepatitis B vaccine.

CIGB Deputy Director General Carlos Borroto described it as a true world scientific breakthrough, and it was obtained after having completed all necessary stages of the technological process required for it.

At a press conference in Havana, Borroto said it was the result of research work similar to what is being developed by research teams from dozens of highly developed nations.

Baptized as CB-Hep.1, the recombinant monoclonal antibody made of plants is of great relevance to increase the production of the anti-hepatitis B vaccine at a lower cost.

From the research point of view, this breakthrough leaves a door opened to obtain other effective antibodies to fight illnesses, including cancer.

(Source:PTI News)

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...